Researchers at Monash University and The Alfred are pioneering a method of analysing blood samples to diagnose concussion in people aged over 60, the world’s most at-risk group for the condition.

All animals, including humans, experience stress. Not the type where you worry about paying bills, but metabolic stress – triggered by starvation, obesity or bacterial infections.

Australia has the highest rate of methamphetamine use disorder in the world, yet treatment outcomes remain consistently poor. Researchers say one of the key reasons people struggle during recovery is the emergence of severe impulsivity.

The Turner Institute for Brain and Mental Health  and Wellcome Leap, are collaborating to accelerate high-impact neuroscience - to deliver safe, effective, and scalable mental health treatments.

A world-first concussion and head impact study led by Monash University will assess the efficacy of headgear during elite and community football and rugby games.

A/Prof Claire Foldi and her team show that movement history and dietary restriction influence how the psychedelic substance affects sociability and immune signaling in a relevant preclinical model.

Monash Biomedicine Discovery Institute (BDI) researchers received seven National Health and Medical Research Council (NHMRC) Ideas Grants for funding commencing in 2026, collectively worth more than $10 million.

The Monash Biomedicine Discovery Institute (BDI) came together in December 2025 to honour the remarkable achievements of its staff and students at the annual Monash BDI Celebration and Awards for Outstanding Achievement ceremony.

The Monash Biomedicine Discovery Institute (BDI) is delighted to announce the appointment of 18 new Group Leaders in 2025.